Literature DB >> 16142383

Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels.

Zhirong Wang1, Jiangang Zou, Kejiang Cao, Tze-Chen Hsieh, Yuanzhu Huang, Joseph M Wu.   

Abstract

Moderate consumption of red wine is associated with a reduced risk of coronary heart disease (CHD). This phenomenon is based on data from epidemiological observations known as the French paradox, and has been attributed to CHD-protective phytochemicals, e.g. resveratrol in red wine. Since red wine also contains alcohol, it is conceivable that alcohol interacts with resveratrol to elicit the observed cardioprotective effects. To determine whether resveratrol has alcohol-independent affects, we compared cardioprotective properties of dealcoholized Chinese red wine with alcohol-containing Chinese red wine having comparable amounts of resveratrol, using a hypercholesterolemic rabbit model and resveratrol as a reference. Animals fed a high cholesterol (1.5%) diet were simultaneously given water containing resveratrol (3 mg/kg/day) or red wine (4 ml/kg/day) containing 3.98 mg/l and 3.23 mg/l resveratrol for regular and dealcoholized red wine, respectively, for a 12-week duration. Total, HDL- and LDL-cholesterol and triglyceride levels in the plasma were measured before and after the cholesterol challenge. Atherosclerotic plaques in the thoracic aorta were evaluated using histochemical methods. Vascular and endothelial functions in the femoral artery were also assessed by ultrasonographic image analysis. High cholesterol-fed animals showed a significant increase in plasma levels of total, HDL- and LDL-cholesterol, but not triglycerides, compared to those fed a regular diet. Dietary cholesterol-elicited lipid changes were similarly observed in animals concurrently fed dealcoholized red wine, red wine or resveratrol. In contrast, whereas atherosclerotic lesions were clearly evident in specimens prepared from the thoracic aorta of high cholesterol-fed animals, the size, density, and mean area of atherosclerotic plaques, and thickness of the intima layer were significantly reduced in rabbits given dealcoholized red wine, red wine, or resveratrol. These results were in agreement with data obtained by an ultrasound analysis of endothelial function, which showed a 25% reduction in flow-mediated dilation (FMD) in rabbits fed a high cholesterol diet compared to animals on control diet. This decrease was effectively prevented by the simultaneous exposure to dealcoholized red wine, red wine, or resveratrol. Our study shows that animals given dealcoholized red wine exhibited cardio-active effects comparable to those of animals orally administered resveratrol, and suggests that wine polyphenolics, rather than alcohol present in red wine, suffice in exerting cardioprotective properties. The results also provide support for the notion that resveratrol and phytochemicals in red wine can suppress atherosclerosis without affecting plasma lipid levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142383

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  39 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues.

Authors:  Joseph M Wu; Tze-Chen Hsieh; Zhirong Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-04-27

Review 3.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

4.  Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.

Authors:  Tamara P Kondratyuk; Eun-Jung Park; Laura E Marler; Soyoun Ahn; Yang Yuan; Yongsoo Choi; Rui Yu; Richard B van Breemen; Bin Sun; Juma Hoshino; Mark Cushman; Katherine C Jermihov; Andrew D Mesecar; Clinton J Grubbs; John M Pezzuto
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

Review 5.  The roles of macrophage autophagy in atherosclerosis.

Authors:  Bo-zong Shao; Bin-ze Han; Yan-xia Zeng; Ding-feng Su; Chong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-01-11       Impact factor: 6.150

6.  Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]

Authors:  Bela Juhasz; Bela Juhaz; Dipak K Das; Attila Kertesz; Akos Juhasz; Rudolf Gesztelyi; Balazs Varga
Journal:  Mol Cell Biochem       Date:  2010-11-04       Impact factor: 3.396

7.  Late chronic catechin antioxidant treatment is deleterious to the endothelial function in aging mice with established atherosclerosis.

Authors:  Marie-Eve Gendron; Jean-François Théorêt; Aida M Mamarbachi; Annick Drouin; Albert Nguyen; Virginie Bolduc; Nathalie Thorin-Trescases; Yahye Merhi; Eric Thorin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

8.  Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy.

Authors:  Hui-Wen Yan; Wei-Xin Hu; Jie-Ying Zhang; Ye Wang; Kun Xia; Min-Yuan Peng; Jing Liu
Journal:  Tumour Biol       Date:  2014-02-15

9.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

10.  Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.

Authors:  George R Pettit; Noeleen Melody; Andrew Thornhill; John C Knight; Thomas L Groy; Cherry L Herald
Journal:  J Nat Prod       Date:  2009-09       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.